About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT03337269

Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake

This study aims to assess the effectiveness of targeted educational interventions in increasing the acceptability and knowledge of the HPV vaccine among females ages 12 through 26. Subjects will be ra...

Lead sponsor: University of Pennsylvania•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Pennsylvania

Age

12 - 26 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•1. Females ages greater than or equal to 12 years and less than or equal to 26 years
•2. Presenting to a gynecology clinic for a routine or problem visit
•3. Ability to read and write

Exclusion Criteria

•1. Women ages less than or greater than 12 years or greater than 26 years
•2. Women with known cervical cancer
•3. Known pregnancy
•4. Prior initiation or completion of the HPV vaccine series

Related studies

RECRUITINGPhase 1/2

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

NCT06319963 · HPV-Related Cervical Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma

RECRUITINGPhase 2

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes

NCT06640283 · HPV-Related Carcinoma, Uterine Cervical Cancer, and more

Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples

NCT06598176 · Uterine Cervical Neoplasm, Uterine Cervical Dysplasia, and more

Active Not RecruitingPhase 1/2

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

NCT03260023 · HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, and more

Self-collected Vaginal and Urine Samples in HIV-positive Women

NCT05783167 · HIV Infections, HPV-Related Cervical Carcinoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 11, 2018Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment256

Start dateMar 2017

Last updatedApr 11, 2018

Condition

HPV-Related Cervical Carcinoma

Locations shown

University of Pennsylvania

Philadelphia, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 11, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions